About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Dsg2tm3.1Leu
targeted mutation 3.1, Rudolf E Leube
MGI:6508032
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Dsg2tm3.1Leu/Dsg2tm3.1Leu
Tg(Vil1-cre)20Syr/0
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 MGI:6693360


Genotype
MGI:6693360
cn1
Allelic
Composition
Dsg2tm3.1Leu/Dsg2tm3.1Leu
Tg(Vil1-cre)20Syr/0
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dsg2tm3.1Leu mutation (0 available); any Dsg2 mutation (79 available)
Tg(Vil1-cre)20Syr mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
N
• normal colon length and intestinal histology
• no diarrhea
• normal intestinal basal cell proliferation
• no intestinal inflammation
• normal desmosomal plaques in intestines
• wider intercellular spaces between desmosomal plaques in small and large intestine
• normal desmosomal plaques in intestines
• stronger inflammatory reaction, hyperproliferation and increased epithelial detachment and crypt elongation in intestines and higher fecal bacterial colony forming unit (CFU) count after Citrobacter rodentium exposure
• normal infection clearance after Citrobacter rodentium exposure
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)

immune system
• stronger inflammatory reaction, hyperproliferation and increased epithelial detachment and crypt elongation in intestines and higher fecal bacterial colony forming unit (CFU) count after Citrobacter rodentium exposure
• normal infection clearance after Citrobacter rodentium exposure
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)

growth/size/body
N
• normal postnatal weight gain and colon length

mortality/aging
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory